ResearcherUniversity of IowaNo recent work listed

Vikas Bhardwaj

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3364-8711; OpenAlex author ID A5045669863. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Aditi Jain · 2 shared papers, 2014–2021 · strength 0.33
- Paper Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities. DOI 10.3748/wjg.v27.i39.6527 ↗
- Paper Biochanin A reduces pancreatic cancer survival and progression. DOI 10.1097/cad.0000000000000044 ↗
Alok Bhushan · 2 shared papers, 2014–2020 · strength 0.19
- Paper Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenas… DOI 10.1186/s40170-020-00226-5 ↗
- Paper Biochanin A reduces pancreatic cancer survival and progression. DOI 10.1097/cad.0000000000000044 ↗
Neha Sharma · 1 shared paper, 2020 · strength 0.15
- Paper Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenas… DOI 10.1186/s40170-020-00226-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.